Report Detail

Other Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026

  • RnM2895588
  • |
  • 19 July, 2019
  • |
  • Global
  • |
  • 197 Pages
  • |
  • IQ4I Research & Consultancy
  • |
  • Other

“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report also covers some of the hot targets in research for NASH treatments and NASH related biomarkers.
This report enables Pharmaceutical/Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Non-alcoholic steatohepataitis (NASH) drugs market. The report also provides strategic insights on some of the molecules that are yet to be launched in the next few years. Some of the key sections covered in the report are given below:
• Epidemiology
o In this section, epidemiology of NASH is reviewed to understand potential significance and impact of the disease.
o Global & US prevalence rates.
• Hot Targets, Mechanisms & Therapies
o In this section, various NASH associated targets, mechanism and upcoming therapies are discussed. Also, covers novel targets in early research for NASH along with disease progression biomarkers associated with NASH (Inflammatory, apoptosis, fibrosis).
• Pipeline Analysis
o Pipeline analysis was carried to get deeper insights on various treatment modalities in discovery, preclinical & development section, pipelines from major companies were identified and Potential targets were reported along with Mechanism of action, Current development status & nature of molecule. Pipeline analysis by developmental stage (Discovery to Clinical development).
o Pipeline analysis by modalities
• Monoclonal Antibodies pipeline analysis
• RNA-therapeutics pipeline analysis
• Recombinant protein pipeline analysis
o Pipeline analysis by leading players & Target analysis
o Drug analysis based on mechanism (Anti-Inflammatory, Anti-fibrotic and Metabolic)


REPORT DESCRIPTION INTRODUCTION

    • Causes & Symptoms

      • Diagnosis

        • Unmet needs

          • Current therapies

            HOT TARGETS, MECHANISMS & THERAPIES

              • Novel Disease mechanisms & therapies

                • Leading targets of NASH

                  • Novel targets of NASH

                    • NASH biomarkers • Genes involved in NASH

                      MARKET DATA

                        • Forecasting model

                          • Market dynamics

                            • Market sizing and peak sales

                              • NASH Deals

                                • Funding Scenario

                                  PIPELINE ANALYSIS

                                    • Development stage

                                      • Leading players

                                        • Molecule Type

                                          • Target analysis

                                            • Clinical Update on Phase 3 molecules

                                              • Innovative approaches

                                                Small molecules

                                                  • Pipeline

                                                    • Competitive landscape Large molecules

                                                      • RNA-BASED THERAPY

                                                        • Pipeline

                                                          • Competitive landscape

                                                            • RECOMBINANT PROTEINS

                                                              • Pipeline

                                                                • Competitive landscape • ANTIBODIES

                                                                  • Pipeline

                                                                    • Competitive landscape LARGE MOLECULES (UNSPECIFIED)

                                                                      • Pipeline

                                                                        OTHER MOLECULES

                                                                          • Pipeline

                                                                            NASH DRUG ANALYSIS BASED ON MECHANISM (CLINICAL)

                                                                              MAJOR PLAYERS

                                                                                • Company Profiles

                                                                                  • Overview, Pipeline & Deals

                                                                                    REFERENCE

                                                                                    Summary:
                                                                                    Get latest Market Research Reports on Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026. Industry analysis & Market Report on Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026 is a syndicated market report, published as Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026. It is complete Research Study and Industry Analysis of Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                    Last updated on

                                                                                    REPORT YOU MIGHT BE INTERESTED

                                                                                    Purchase this Report

                                                                                    $3,600.00
                                                                                    $5,400.00
                                                                                    $7,200.00
                                                                                    2,851.20
                                                                                    4,276.80
                                                                                    5,702.40
                                                                                    3,333.60
                                                                                    5,000.40
                                                                                    6,667.20
                                                                                    544,860.00
                                                                                    817,290.00
                                                                                    1,089,720.00
                                                                                    300,240.00
                                                                                    450,360.00
                                                                                    600,480.00
                                                                                    Credit card Logo

                                                                                    Related Reports


                                                                                    Reason to Buy

                                                                                    Request for Sample of this report